Dna Group (T.R.) Ltd
DNA.TA
Price:
$111
Market Cap:
$136.71M
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.)...[Read more]
Industry
Biotechnology
IPO Date
2007-12-04
Stock Exchange
TLV
Ticker
DNA.TA
PE Ratio
[6.17]
ROE
[0.52%]
Current Ratio
[48.83]
Dividend Yield
[0%]
Enterprise Value
[66.39M]
Dividend History
The ROE as of December 2025 (TTM) for Dna Group (T.R.) Ltd (DNA.TA) is 0.52%
According to Dna Group (T.R.) Ltd’s latest financial reports and current stock price. The company's current ROE is 0.52%. This represents a change of 395.19% compared to the average of 0.10% of the last 4 quarters.
Dna Group (T.R.) Ltd (DNA.TA) Historical ROE (quarterly & annually)
How has DNA.TA ROE performed in the past?
The mean historical ROE of Dna Group (T.R.) Ltd over the last ten years is -13.39%. The current 0.52% ROE has changed -103.86% with respect to the historical average. Over the past ten years (40 quarters), DNA.TA's ROE was at its highest in in the March 2021 quarter at 18.69%. The ROE was at its lowest in in the September 2020 quarter at -59.95%.
Average
-13.39%
Median
2.82%
Minimum
-242.30%
Maximum
213.23%
Dna Group (T.R.) Ltd (DNA.TA) ROE by Quarter and Year
Discovering the peaks and valleys of Dna Group (T.R.) Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.89%
Maximum Annual ROE = 213.23%
Minimum Annual Increase = -1565.13%
Minimum Annual ROE = -242.30%
| Year | ROE | Change |
|---|---|---|
| 2024 | 21.78% | -1565.13% |
| 2023 | -1.49% | -94.94% |
| 2022 | -29.38% | -186.88% |
| 2021 | 33.82% | -113.96% |
| 2020 | -242.30% | 77.22% |
| 2019 | -136.72% | 521.11% |
| 2018 | -22.01% | -110.32% |
| 2017 | 213.23% | 2.89% |
| 2016 | 7.13% | -67.75% |
| 2015 | 22.09% | -79.51% |
Dna Group (T.R.) Ltd (DNA.TA) Average ROE
How has DNA.TA ROE performed in the past?
The current ROE of Dna Group (T.R.) Ltd (DNA.TA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.03%
5-year avg
-43.51%
10-year avg
-13.39%
Dna Group (T.R.) Ltd (DNA.TA) ROE vs. Peers
How is DNA.TA’s ROE compared to its peers?
Dna Group (T.R.) Ltd’s ROE is greater than Geffen Residence & Renewal Ltd (-11.09%), less than G.F.C Green Fields Capital Ltd. (0.01%), less than Golden House Ltd (30.14%), less than Kadimastem Ltd (0.16%), greater than Bonus BioGroup Ltd. (-824.03%), less than Pluri Inc. (468.40%), greater than Enlivex Therapeutics Ltd. (-62.91%), less than Pulsenmore Ltd. (1.79%), greater than Rekah Pharmaceutical Industry Ltd. (-8.39%), greater than Can-Fite BioPharma Ltd. (-182.93%),
| Company | ROE | Market cap |
|---|---|---|
| -11.09% | $178.82M | |
| 0.01% | $136.14M | |
| 30.14% | $181.54M | |
| 0.16% | $125.73M | |
| -824.03% | $291.98M | |
| 468.40% | $78.84M | |
| -62.91% | $86.08M | |
| 1.79% | $132.69M | |
| -8.39% | $133.78M | |
| -182.93% | $51.22M |
Build a custom stock screener for Dna Group (T.R.) Ltd (DNA.TA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dna Group (T.R.) Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dna Group (T.R.) Ltd (DNA.TA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dna Group (T.R.) Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Dna Group (T.R.) Ltd's ROE?
How is the ROE calculated for Dna Group (T.R.) Ltd (DNA.TA)?
What is the highest ROE for Dna Group (T.R.) Ltd (DNA.TA)?
What is the 3-year average ROE for Dna Group (T.R.) Ltd (DNA.TA)?
What is the 5-year average ROE for Dna Group (T.R.) Ltd (DNA.TA)?
How does the current ROE for Dna Group (T.R.) Ltd (DNA.TA) compare to its historical average?